Researchers will use GE HealthCare’s StarGuide SPECT/CT imaging system together with MIM Software’s MIM LesionID Pro platform to monitor how tumours respond throughout treatment.
Researchers found that postmenopausal women taking hormone therapy while receiving tirzepatide lost approximately 35% more weight than women treated with tirzepatide alone.
Unlike CAR-T therapy, which requires patient-specific cell modification and lengthy manufacturing, this treatment is delivered as a ready-to-use infusion, making it more accessible in standard hospital settings.
Unlike most forms of dementia, which typically worsen gradually over many years, RPD progresses at an alarming pace and can lead to severe disability or death within one to two years.
Researchers found that nearly all major DNA methylation changes were associated with tau accumulation rather than amyloid plaques.
Alzheimer’s disease is characterized by the accumulation of tau protein in the brain, which gradually damages nerve cells and impairs memory and cognitive function.
Built on the Mayo Clinic Platform, the system operates within a secure environment where Mayo Clinic teams can access large volumes of de-identified patient data.
The study suggests that tracking sleep patterns before rehabilitation begins could help healthcare teams identify patients who may need extra support to stay engaged throughout treatment.
Falls represent one of the most serious health threats facing older adults, yet Mayo Clinic scientists have found that warning signs may already be visible in imaging tests that people undergo for entirely different reasons.
The device transmits this data to an artificial intelligence-powered app on the parent’s smartphone, which analyzes the information in real time.